Lenvatinib Mesylate Intermediate CAS 205448-65-3 Bohloeki >98.0% (HPLC) Factory
Ruifu Chemical Supply Lenvatinib Mesylate Intermediates Ka Bohloeki bo Phahameng
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Lebitso la Lik'hemik'hale | Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate |
Litlhaloso tse tšoanang | 1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;Lenvatinib ea Hare 3 |
Nomoro ea CAS | 205448-65-3 |
Nomoro ea KAtse | RF-PI1973 |
Boemo ba Setoko | Ka Setokong, Bokhoni ba Tlhahiso 50 MT / Selemo |
Foromo ea limolek'hule | C12H11NO4 |
Boima ba Molek'hule | 233.22 |
Ntlha e belang | 421.0±45.0℃ |
Botenya | 1.267±0.060 g/cm3 |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Phofo e Tletseng-Bosoeu ho isa ho Bosehla |
Mokhoa oa Bohloeki / Analysis | >98.0% (HPLC) |
Tahlehelo ka ho Omisa | <1.00% |
Masalla a ho Ignition | <0.50% |
Litšila ka Kakaretso | <2.00% |
H-NMR | E Ikamahanya le Sebopeho |
Tekanyetso ea Teko | Maemo a Khoebo |
Tšebeliso | Mekhatlo ea Meriana |
Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) ke bohareng ba Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib, e rekisoang ka lebitso la Lenvima har'a tse ling, ke moriana o thibelang mofetše bakeng sa ho alafa mefuta e itseng ea mofetše oa qoqotho le mefetše e meng hape.E entsoe ke Eisai Co. 'me e sebetsa e le multiple kinase inhibitor khahlanong le VEGFR1, VEGFR2 le VEGFR3 kinases.Lenvatinib e amohetsoe (ho tloha 2015) bakeng sa kalafo ea mofets'e oa qoqotho o fapaneng oo e ka bang o ipheta-pheta kapa oa metastatic, o tsoelang pele, o sa arabeleng kalafo ka radioactive iodine (radioiodine).Ka May 2016, US Food and Drug Administration (FDA) e ile ea e amohela (hammoho le everolimus) bakeng sa phekolo ea kankere ea kankere ea renal e tsoetseng pele ka mor'a phekolo e le 'ngoe ea pele ea anti-angiogenic.Setlhare sena se boetse se amohetsoe US le European Union bakeng sa kankere ea sebete ea hepatocellular e ke keng ea tlosoa ka ho buuoa ho bakuli ba sa kang ba fumana phekolo ea kankere ka molomo kapa ka ente.